ArticleBreast cancer (Tokyo, Japan)2024

Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.

Yuhang Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.